EUVIMEDEUVIMED entdecken
Open Access

Re-evaluating perioperative and neoadjuvant immunotherapy in early-stage lung cancer: Current evidence and discussions

Enes Erul

Tuberk Toraks · 23.03.2025 · 73 (1) · 80-84

DOI: 10.5578/tt.2025011040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tuberk Toraks, online erschienen am 24.03.2025. Verfasst von Enes Erul. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Türkiye. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Türkiye.

Zitieren

APA

Erul, E. (2025). Re-evaluating perioperative and neoadjuvant immunotherapy in early-stage lung cancer: Current evidence and discussions. Tuberk Toraks, 73(1), 80-84. https://doi.org/10.5578/tt.2025011040

Vancouver

Erul E. Re-evaluating perioperative and neoadjuvant immunotherapy in early-stage lung cancer: Current evidence and discussions. Tuberk Toraks. 2025;73(1):80-84. doi:10.5578/tt.2025011040

BibTeX
@article{Erul2025,
  author = {Erul, Enes},
  title = {Re-evaluating perioperative and neoadjuvant immunotherapy in early-stage lung cancer: Current evidence and discussions},
  journal = {Tuberk Toraks},
  year = {2025},
  volume = {73},
  number = {1},
  pages = {80--84},
  doi = {10.5578/tt.2025011040}
}
Kostenlos starten →